Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sagard Healthcare Partners Funding Borrower SPE 2 is a special purpose entity managed by Sagard Healthcare Partners, the healthcare-focused investment arm of the global alternative asset manager Sagard. The entity serves as a financing vehicle for the firm's activities in healthcare royalty monetization and structured credit, providing non-dilutive capital to biotech and pharmaceutical companies. Sagard Healthcare Partners specializes in acquiring royalty interests in FDA-approved or late-stage clinical products and providing senior secured loans. Their investment strategy focuses on high-quality, protected healthcare assets across diverse therapeutic areas including oncology, neurology, and rare diseases. The firm's capital solutions are designed to help healthcare companies fund R&D, product launches, and strategic acquisitions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sagard Healthcare Partners Funding Borrower SPE 2.